Somnomed Ltd

Somnomed Ltd

SOM · AU · Healthcare / Medical Devices

0.32AUD+0.03 (+10.34%)

Price History

Full chart

Market Stats

Previous Close0.29
Open0.32
Day Range0.31 – 0.32
52-Week Range0.29 – 0.945
Volume23.54K
Market Cap63.73M
P/E (TTM)0.00
Forward P/E0.20
EPS-0.01
Dividend Yield0.00%
Beta0.78
50-Day Avg0.3602
200-Day Avg0.5518

About

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Karen Borg B.A.
  • Employees0
  • Headquarters20 Clarke Street, Crows Nest, NSW, Australia, 2065, Australia
  • Websitehttps://somnomed.com/au/

Leadership

  • Ms. Karen Borg B.A.CEO & Executive Director
  • Ms. Ye-Fei GuoChief Financial Officer
  • Mr. Greg KnightChief Operating Officer
  • Mr. David LewisChief Information Officer
  • Mr. Nathan MinnichChief Marketing Officer
  • Ms. Janice Hiskett-JonesChief People Officer
  • Mr. Marco Van KleefPresident of Europe
  • Mr. Keshan GunasingheChief Product Officer
  • Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., SF FINCompany Secretary · b. 1959
  • Mr. Christopher BedfordVice President of Global Production and Product Development

Financials

Income Statement

Currency: AUD2004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue28.15K377.12K1.79M2.27M3.66M8.00M10.99M12.51M15.33M18.49M30.27M34.44M44.08M49.33M52.39M58.89M57.30M62.71M72.58M83.62M91.65M111.49M114.53M
Growth (%)-+1239.83%+373.56%+27.30%+60.91%+118.56%+37.48%+13.84%+22.50%+20.62%+63.74%+13.75%+28.01%+11.89%+6.22%+12.40%-2.71%+9.44%+15.75%+15.20%+9.61%+21.65%+2.73%
Cost of Revenue51.42K349.13K985.34K1.27M1.70M3.68M4.63M4.16M4.89M6.22M13.46M14.95M18.74M20.52M20.54M24.32M27.28M28.80M33.43M37.85M36.52M44.76M53.62M
Gross Profit-23.27K27.99K800.58K1.00M1.96M4.32M6.36M8.35M10.44M12.27M16.81M19.49M25.34M28.81M31.86M34.57M30.01M33.90M39.15M45.77M55.13M66.73M60.91M
Gross Margin-82.69%7.42%44.83%44.08%53.49%53.99%57.88%66.76%68.11%66.35%55.52%56.60%57.49%58.41%60.80%58.70%52.38%54.07%53.94%54.74%60.15%59.85%53.18%
Operating Expense540.38K3.66M5.36M4.76M4.83M6.29M6.34M7.83M9.98M12.06M16.50M19.45M25.23M32.54M29.85M33.65M30.96M34.56M43.28M49.84M63.46M63.11M59.94M
Operating Income-563.65K-3.63M-4.55M-3.75M-2.87M-1.97M18.30K521.51K458.72K204.50K314.70K40.72K117.56K-3.73M2.00M918.46K-940.98K-651.38K-4.13M-4.07M-8.33M3.62M976.00K
Operating Margin-2002.54%-963.18%-255.03%-165.15%-78.55%-24.63%0.17%4.17%2.99%1.11%1.04%0.12%0.27%-7.57%3.83%1.56%-1.64%-1.04%-5.69%-4.87%-9.09%3.24%0.85%
EBITDA-562.73K-3.61M-4.02M-2.91M-2.26M-1.65M174.69K742.33K900.28K707.78K849.36K573.33K1.51M-2.51M3.67M3.12M4.31M3.57M524.53K698.39K-2.33M1.58M6.46M
EBITDA Margin-1999.26%-957.07%-224.89%-128.06%-61.67%-20.64%1.59%5.93%5.87%3.83%2.81%1.66%3.43%-5.09%7.00%5.29%7.51%5.70%0.72%0.84%-2.54%1.42%5.64%
Net Income-557.00K-3.27M-4.19M-3.27M-2.73M-1.82M786.14K739.54K524.68K588.79K405.86K597.22K165.00K-3.34M2.32M-39.39K-1.12M-1.19M-4.44M-8.00M-12.24M-3.46M-2.65M
Net Income Margin-1978.89%-866.20%-234.52%-144.03%-74.66%-22.75%7.15%5.91%3.42%3.18%1.34%1.73%0.37%-6.78%4.42%-0.07%-1.95%-1.90%-6.11%-9.57%-13.36%-3.10%-2.31%
R&D----1.41M1.79M1.77M2.30M2.36M578.89K630.81K743.12K880.53K953.69K949.10K1.06M904.29K958.18K978.38K705.85K1.04M1.82M1.74M
R&D as % of Total Revenue----38.42%22.34%16.09%18.41%15.37%3.13%2.08%2.16%2.00%1.93%1.81%1.80%1.58%1.53%1.35%0.84%1.14%1.63%1.52%
Interest Expense020.34K29.94K15.79K9.47K0000012.75K19.07K10.72K20.42K199.59K205.27K473.09K469.19K380.33K2.63M3.17M398.50K464.00K
Interest Expense % of Total Revenue0.00%5.39%1.68%0.69%0.26%0.00%0.00%0.00%0.00%0.00%0.04%0.06%0.02%0.04%0.38%0.35%0.83%0.75%0.52%3.14%3.46%0.36%0.41%

Balance Sheet

Currency: AUD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets118.00K624.71K7.92M4.07M4.70M7.00M6.04M7.83M8.73M12.31M18.30M19.14M27.75M40.43M41.21M45.70M34.75M61.69M56.17M58.09M62.49M69.80M80.97M75.00M
Total Liabilities3.00K784.78K716.30K834.72K785.50K995.73K1.70M2.18M2.51M3.39M6.73M6.57M6.24M7.74M10.26M12.93M16.93M27.86M24.01M30.31M40.09M24.78M34.58M27.60M
Total Equity115.00K-160.08K7.20M3.23M3.91M6.01M4.33M5.65M6.22M8.44M11.40M12.34M21.34M33.13M32.21M36.12M17.82M33.84M32.16M27.79M22.40M45.02M46.39M47.40M
Cash107.00K51.27K6.64M2.31M3.20M5.43M4.01M4.29M3.95M3.54M4.22M2.94M8.31M17.63M14.21M13.38M7.70M30.17M21.11M15.64M11.96M16.18M17.29M17.18M
Total Debt--411.75K250.88K91.78K--6.31K------122.55K1.44M3.60M15.53M8.91M12.01M23.51M6.72M8.03M5.46M
Net Debt--51.27K-6.22M-2.06M-3.11M-5.43M-4.01M-4.29M-3.95M-3.54M-4.22M-2.94M-8.31M-17.63M-14.09M-11.95M-4.10M-14.64M-12.20M-3.63M11.55M-9.46M-9.27M-11.73M

Cash Flow

Currency: AUD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--268.63K-3.43M-3.75M-2.34M-2.12M-1.32M461.46K172.68K289.78K572.00K-790.41K-242.22K2.11M-2.68M-9.47M-6.55M5.19M2.71M1.86M-3.88M-6.33M7.78M8.28M
Investing Cash Flow91.00K-16.40K-1.02M-416.51K500-163.22K-106.17K-526.82K-237.91K-782.42K-792.65K-395.95K-1.51M-3.23M-2.74M-2.20M-1.63M-1.83M-4.37M-8.47M-6.41M-5.34M-3.98M-5.74M
Financing Cash Flow-229.45K11.04M-160.88K3.25M4.51M-436.00K334.00K154.15K540.75K-43.89K7.06M10.46M2.28M10.54M2.38M18.87M-6.80M2.09M6.61M16.68M-3.38M-1.47M
Capital Expenditure027.89K672.75K416.51K20.78K120.82K97.00K526.82K426.38K481.84K198.02K314.40K1.18M1.91M2.39M2.01M1.34M2.19M4.13M8.79M6.41M1.39M2.42M3.26M
Free Cash Flow--296.52K-4.11M-4.16M-2.36M-2.24M-1.41M-65.35K-253.70K-192.06K373.99K-1.10M-1.42M197.05K-5.07M-11.48M-7.89M3.00M-1.43M-6.93M-10.29M-7.72M5.36M5.02M
Dividends Paid-------------00-4.96M20.10M------
FCF to OCF-110.38%119.60%111.11%100.89%105.71%107.36%-14.16%-146.92%-66.28%65.38%139.78%586.43%9.36%189.28%121.23%120.45%57.89%-52.71%-373.08%265.32%121.90%68.89%60.61%
Dividend Paid to FCF-------------0.00%0.00%--62.88%668.95%------

Earnings

Report DateFeb 22, 2016Aug 18, 2016Feb 22, 2017Aug 23, 2017Feb 18, 2018May 30, 2018Aug 21, 2018Nov 28, 2018Feb 20, 2019May 3, 2019Aug 20, 2019Nov 27, 2019Feb 17, 2020Jun 3, 2020Aug 23, 2020Dec 2, 2020Feb 22, 2021Jun 2, 2021Aug 23, 2021Dec 1, 2021Feb 21, 2022Apr 26, 2022Aug 23, 2022Oct 25, 2022Feb 22, 2023Apr 28, 2023Aug 31, 2023Oct 30, 2023Feb 27, 2024Jun 27, 2024Aug 27, 2024Nov 27, 2024Feb 27, 2025May 30, 2025Aug 27, 2025Dec 3, 2025Apr 29, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.00-0.00-0.00-0.000.000.000.00-0.020.00-0.040.00-0.010.00-0.020.000.000.000.00
EPS Actual0.000.00-0.01-0.05-0.070.00-0.050.000.000.000.000.000.010.00-0.020.000.010.00-0.020.00-0.040.00-0.020.00-0.050.000.000.000.000.000.000.000.000.00-0.020.000.00
Surprise-----------------------9900.00%---100.00%-100.00%-100.00%-100.00%----
Timing--------------------After-hours-Pre-marketPre-market-Pre-marketAfter-hoursAfter-hours-Pre-market-------

Key Statistics & Ratios

Market Cap63.73M
Enterprise Value59.70M
Trailing P/E0.00
Forward P/E0.20
PEG Ratio0.99
Price / Sales0.56
Price / Book1.51
EPS-0.01
Book Value0.216
Revenue (TTM)114.53M
Gross Profit (TTM)70.02M
EBITDA3.01M
Profit Margin-2.31%
Operating Margin-3.40%
Return on Equity-5.65%
Return on Assets0.78%
Shares Outstanding219.77M
Shares Float101.02M
Beta0.78
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
63.37%
Insiders
26.01%
Retail / Other
10.62%

Top Fund Holders

  • Fidelity International Small Cap Fund
    3.90M4.71%
  • DFA Asia Pacific Small Company Series
    25.16K0.03%

Stock Splits

  • Nov 26, 20091:20